Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam vs Propofol for induction and maintenance of anesthesia in adult elective surgery
ChiCTR2600122664Phase 4Not yet recruiting
- Sponsor
- Shaoxing People's Hospital
- Start
- Apr 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of remimazolam (2 arms), sponsored by Shaoxing People's Hospital. Primary endpoint: Incidence of postoperative nausea and vomiting (PONV). Planned start Apr 2026; status: not yet recruiting.
02
Drugs
remimazolam
Beyond the preview
Go deeper on ChiCTR2600122664.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2600122664.